| Literature DB >> 31131058 |
Kun Yin1, Vikram Pandian1, Karteek Kadimisetty1, Carlos Ruiz1, Kumarasen Cooper2, Jianxin You3, Changchun Liu1,4.
Abstract
Rationale: Early and accurate detection of disease is crucial for its prevention, identification, and treatment. However, most of disease diagnostics is still limited in clinical laboratories due to the need of complicated instruments and professional personnel. Herein, we reported a smartphone-based synergistically enhanced colorimetric method for molecular diagnostics in our point of care (POC) smart cup platform.Entities:
Keywords: HPV-associated cancer screening; hue based colorimetric detection; point-of-care testing; synergistic enhancing effect
Year: 2019 PMID: 31131058 PMCID: PMC6525999 DOI: 10.7150/thno.32224
Source DB: PubMed Journal: Theranostics ISSN: 1838-7640 Impact factor: 11.556
Figure 1Synergistically enhanced colorimetric detection strategy of LAMP assay in non-buffered reaction solution. (A) Detection mechanism. (B) Colorimetric detection and hue value analysis of HNB indicator with 4, 6 and 8 mM Mg2+ at a constant pH value (8.8) and various pH values (8.8 to 6.8), respectively. (C) Colorimetric LAMP detection of HPV 16 DNA and hue value analysis in non-buffered LAMP solution and NEB LAMP reaction buffer, respectively. Error bars denote s.d. (n=3).
Figure 2Comparison of smartphone-based hue value analysis method and traditional absorption spectrometry in colorimetric detection. (A) Custom app interface. (B) Optical image of tubes containing 120 µM HNB indicator and various Mg2+ ion concentrations. (C) Hue values of HNB indicator as a function of various concentrations of Mg2+ ions. (D) Absorption spectra of HNB with various Mg2+ ion concentrations. (E) Absorbance peak of HNB indicator at 650 nm as a function of various Mg2+ ion concentrations. Error bars denote s.d. (n=3).
Figure 3HPV DNA detection in saliva samples in our POC diagnostic platform. (A) Photographs of four-chamber microfluidic chip (top) and smart cup equipped with smartphone (bottom). (B) Screenshots of the app interfaces: imaging/ parameter setting (left) and hue value quantitative readout (right). (C) Detection of saliva samples spiked 103 copies of HPV 16, 18 and 31, respectively. *** indicates a significant difference in the hue value (p < 0.001, t-test). Error bars denote s.d. (n=3).
Figure 4Cervical cancer screening with clinical swab samples in our POC diagnostic platform. (A) Screening workflow. (B) Detection results of our smart cup platform. Red dash box indicates positive. (C) Pap smear results (HSIL: High-Grade Squamous Intraepithelial Lesion; NILM: Negative for Intraepithelial Lesion or Malignancy).
Cervical cancer screening with clinical swab samples by our smart cup platform, real-time PCR method and Pap smear test.
| Clinical swab samples | Smart cup platform | Real time PCR | Pap smear test | ||||
|---|---|---|---|---|---|---|---|
| HPV16 | HPV18 | HPV31 | HPV16 | HPV18 | HPV31 | ||
| 1 | - | - | - | - | - | - | NILM |
| 2 | - | - | - | - | - | - | NILM |
| 3 | - | - | - | - | - | - | NILM |
| 4 | - | - | - | - | - | - | NILM |
| 5 | - | - | - | - | - | - | NILM |
| 6 | - | - | - | - | - | - | NILM |
| 7 | - | - | - | - | - | - | NILM |
| 8 | - | - | - | - | - | - | NILM |
| 9 | - | - | - | - | - | - | NILM |
| 10 | - | - | - | - | - | - | NILM |
| 11 | - | - | - | - | - | - | NILM |
| 12 | - | - | - | - | - | - | NILM |
| 13 | - | - | + | - | - | + | HSIL |
| 14 | - | + | - | - | + | - | ASCUS |
| 15 | + | - | - | + | - | - | HSIL |
+: detected; -: not detected; NILM: Negative for Intraepithelial Lesion or Malignancy; HSIL: High-Grade Squamous Intraepithelial Lesion; ASCUS: Atypical squamous cells of undetermined significance